Lysophospholipid Receptors, as Novel Conditional Danger Receptors and Homeostatic Receptors Modulate Inflammation - Novel Paradigm and Therapeutic Potential

There are limitations in the current classification of danger associated molecular patterns (DAMP) receptors. To overcome these limitations, we propose a new paradigm by using endogenous metabolites lysophospholipids (LPLs) as a prototype. By utilizing a data mining method we pioneered, we made the...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cardiovasc Transl Res
Auteurs principaux: Wang, Xin, Li, Ya-Feng, Nanayakkara, Gayani, Shao, Ying, Liang, Bin, Cole, Lauren, Yang, William Y., Li, Xinyuan, Cueto, Ramon, Yu, Jun, Wang, Hong, Yang, Xiao-Feng
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4992420/
https://ncbi.nlm.nih.gov/pubmed/27230673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-016-9700-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires